The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology
The 2022 OncoAlert Colloquium Day 3: Lung Cancer
The 2022 OncoAlert Colloquium Day 2: GU Oncology
The 2022 OncoAlert Colloquium Day 1: Breast Cancer
Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML
Optimisation of supportive, palliative and end of life care
Adjuvant endocrine therapy +/- 1 year of everolimus fails to improve iDFS and OS in patients with high-risk HR+, HER2-negative BC
Access to Oncology Medicines Coalition - The Medicines Patent Pool
IGHER provides support for African healthcare research, clinical trials and personalised medicine
Cancer survivors' stories: An African perspective
ESMO 2022: Breast and ovarian trial analysis
Neoadjuvant immunotherapy improves outlook in high-risk melanoma